Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

Christopher A. Wall; Paul E. Croarkin; Cosima Swintak; Brett A. Koplin

doi:10.1016/j.chc.2012.07.001

Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

Christopher A. Wall, Paul E. Croarkin, Cosima Swintak, Brett A. Koplin

Psychiatry and Psychology

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

Original language	English (US)
Pages (from-to)	773-788
Number of pages	16
Journal	Child and Adolescent Psychiatric Clinics of North America
Volume	21
Issue number	4
DOIs	https://doi.org/10.1016/j.chc.2012.07.001
State	Published - Oct 2012

Keywords

Dopamine
Metabolism
Pediatric
Pharmacogenomics
Psychopharmacology
Receptor
Serotonin
Transporter

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Psychiatry and Mental health

Access to Document

10.1016/j.chc.2012.07.001

Cite this

@article{22a5fd1f7a25416ba170997f4761b441,

title = "Psychiatric Pharmacogenomics in Pediatric Psychopharmacology",

abstract = "This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.",

keywords = "Dopamine, Metabolism, Pediatric, Pharmacogenomics, Psychopharmacology, Receptor, Serotonin, Transporter",

author = "Wall, {Christopher A.} and Croarkin, {Paul E.} and Cosima Swintak and Koplin, {Brett A.}",

year = "2012",

month = oct,

doi = "10.1016/j.chc.2012.07.001",

language = "English (US)",

volume = "21",

pages = "773--788",

journal = "Child and Adolescent Psychiatric Clinics of North America",

issn = "1056-4993",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

AU - Wall, Christopher A.

AU - Croarkin, Paul E.

AU - Swintak, Cosima

AU - Koplin, Brett A.

PY - 2012/10

Y1 - 2012/10

N2 - This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

AB - This article provides an overview of where psychiatric pharmacogenomic testing stands as an emerging clinical tool in modern psychotropic prescribing practice, specifically in the pediatric population. This practical discussion is organized around the state of psychiatric pharmacogenomics research when choosing psychopharmacologic interventions in the most commonly encountered mental illnesses in youth. As with the rest of the topics on psychopharmacology for children and adolescents in this publication, a clinical vignette is presented, this one highlighting a clinical case of a 16 year old genotyped during hospitalization for recalcitrant depression.

KW - Dopamine

KW - Metabolism

KW - Pediatric

KW - Pharmacogenomics

KW - Psychopharmacology

KW - Receptor

KW - Serotonin

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=84867045867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867045867&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2012.07.001

DO - 10.1016/j.chc.2012.07.001

M3 - Review article

C2 - 23040901

AN - SCOPUS:84867045867

SN - 1056-4993

VL - 21

SP - 773

EP - 788

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

IS - 4

ER -

Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this